Alnylam Pharmaceuticals
ALNY
#690
Rank
NZ$64.46 B
Marketcap
NZ$482.81
Share price
-2.12%
Change (1 day)
-5.41%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company